Among men with abnormal levels by any criterion (except PSA velocity), 40% to 55% of those who did not develop documented prostate cancer in the interim exhibited subsequent normal values.

Initially approved to monitor disease progression in the 1980s and cancer screening in the late 1990s, the PSA test is a simple blood test that can indicate prostate problems when levels are elevated.

Introduction: Physical activity is becoming more important in cancer patient care. However, there are limited studies investigating physical activity levels in cancer survivors after ...

By measuring elevated PSA levels, a recognized early marker of prostate disease, the test can enable early detection of prostate cancer and other prostate-related conditions. This rapid and accessible ...

Levels of the most significant planet-warming gas in our atmosphere rose more quickly than ever previously recorded last year, scientists say, leaving a key global climate target hanging by a thread.

By measuring elevated PSA levels, a recognized early marker of prostate disease, the test can enable early detection of prostate cancer and other prostate-related conditions. This rapid and ...

This test, which delivers results in 10 minutes from a simple finger-prick blood sample, is designed to detect early signs of prostate cancer by measuring elevated PSA levels. The approval marks a ...

The results suggest that measuring CD74 levels could predict whether someone with bowel cancer will respond to immunotherapy, independent of which type they have. Crucially, this means that some ...

If your PSA level is high, you may get a biopsy to find out whether you have prostate cancer or something else like benign prostatic hyperplasia (a swollen prostate). If you do have prostate ...

LONDON — The Ontario government is connecting more people to care by being the first Canadian jurisdiction to publicly fund and administer PLUVICTO TM a new treatment for advanced-stage prostate ...

A BREAKTHROUGH in prostate cancer diagnosis has emerged with the development of an interpretable machine learning model that reduces the need for invasive biopsies in patients with PSA levels below 20 ...